Description

Molecular Details

• Molecular Formula: C165H271N47O46

• Molecular Weight: ~ 3647.3 g/mol

• Peptide Type: Growth Hormone Releasing Hormone (GHRH) analog

• Modification: Attached to Drug Affinity Complex (DAC), which binds to serum albumin, dramatically extending half-life.

Mechanism of Action (Research Use Only)

CJC-1295 with DAC works by mimicking endogenous GHRH, stimulating the pituitary to release growth hormone (GH), which subsequently increases IGF-1 levels.

Key points:

• DAC modification allows binding to serum proteins, extending half-life to about 5–8 days (vs. ~30 minutes for CJC-1295 without DAC).

• Provides sustained GH release rather than pulsatile bursts.

• Designed for less frequent dosing in research models.

Research Applications

• Endocrine and metabolic studies involving GH/IGF-1 axis.

• Muscle and tissue regeneration models.

• Bone density and cartilage support in GH-related studies.

• Anti-aging and longevity research focused on anabolic pathways.

Storage & Handling (Research Use Only)

• Form: Lyophilized peptide powder.

• Storage:

  • Lyophilized: −20 °C long term.

  • Reconstituted: 2–8 °C (stable ~7–10 days).

• Reconstitution: Sterile bacteriostatic water.

• Solubility: Fully water-soluble.

• Use: For laboratory research only. Not for human or veterinary use.